Ventyx Biosciences Inc (NASDAQ: VTYX) on Monday, plunged -6.30% from the previous trading day, before settling in for the closing price of $2.38. Within the past 52 weeks, VTYX’s price has moved between $1.67 and $11.48.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 36.44%. With a float of $53.00 million, this company’s outstanding shares have now reached $70.67 million.
Let’s determine the extent of company efficiency that accounts for 80 employees. In terms of profitability, gross margin is -4.74%, operating margin of -15258.18%, and the pretax margin is -14175.09%.
Ventyx Biosciences Inc (VTYX) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 25.04%, while institutional ownership is 63.94%. The most recent insider transaction that took place on Dec 27 ’24, was worth 49,841. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 21,119 shares at a rate of $2.36, taking the stock ownership to the 464,582 shares. Before that another transaction happened on Dec 27 ’24, when Company’s Officer proposed sale 21,119 for $2.36, making the entire transaction worth $49,842.
Ventyx Biosciences Inc (VTYX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.44% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 23.52 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Looking closely at Ventyx Biosciences Inc (NASDAQ: VTYX), its last 5-days average volume was 1.49 million, which is a drop from its year-to-date volume of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 34.48%. Additionally, its Average True Range was 0.21.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 32.56%, which indicates a significant increase from 5.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.10% in the past 14 days, which was lower than the 82.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.29, while its 200-day Moving Average is $3.10. However, in the short run, Ventyx Biosciences Inc’s stock first resistance to watch stands at $2.34. Second resistance stands at $2.45. The third major resistance level sits at $2.53. If the price goes on to break the first support level at $2.15, it is likely to go to the next support level at $2.07. Should the price break the second support level, the third support level stands at $1.96.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 157.68 million based on 70,711K outstanding shares. Right now, sales total 0 K and income totals -192,960 K. The company made 0 K in profit during its latest quarter, and -35,250 K in sales during its previous quarter.
